Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
HYZAAR
Generic name / active ingredient
losartan potassium and hydrochlorothiazide
Dosage-form class
Fixed two-ingredient losartan potassium/hydrochlorothiazide film-coated oral tablets: 50/12.5 mg, 100/12.5 mg and 100/25 mg; each pair describes two ingredients in one tablet
Route
Oral
Record reviewed
2026-08-29

Copy from the pack in hand

Source-linked reading points

  • Check the active ingredients on every pack. COZAAR is losartan alone, MICROZIDE is hydrochlorothiazide alone, and AVALIDE and EXFORGE HCT also contain hydrochlorothiazide. If any appear together with HYZAAR, do not remove or add a pack yourself; a pharmacist or prescriber must use the complete prescriptions to determine whether use is intentional or duplicative.
  • Dizziness, fainting, marked weakness, thirst, clearly reduced urine, persistent vomiting or diarrhoea, muscle weakness or cramps, or an abnormal heartbeat may accompany changes in blood pressure, fluid balance, kidney function or electrolytes. Use local emergency services for severe or sudden symptoms or altered consciousness.
  • Do not use potassium supplements or potassium-containing salt substitutes without professional review. Lithium, NSAID pain medicines, other medicines affecting the renin-angiotensin system and other diuretic or blood-pressure medicines all require review against the complete medicine list.
  • Sudden eye pain, rapidly reduced vision or marked blurred vision requires prompt medical assessment. Swelling of the face, lips, tongue or throat, breathing difficulty or fainting requires local emergency services.

Reviewed presentation examples — compare every field

  • Losartan potassium 50 mg plus hydrochlorothiazide 12.5 mg per tablet; 30-tablet bottleNDC 78206-139-01
  • Losartan potassium 100 mg plus hydrochlorothiazide 12.5 mg per tablet; 30-tablet bottleNDC 78206-140-01
  • Losartan potassium 100 mg plus hydrochlorothiazide 25 mg per tablet; 30-tablet bottleNDC 78206-141-01

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-29
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image